Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 251

1.

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Dreyling M, Geisler C, Hermine O, Kluin-Nelemans HC, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii83-92. doi: 10.1093/annonc/mdu264. No abstract available.

2.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo V, Eisen T, Horwich A; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii49-56. doi: 10.1093/annonc/mdu259. No abstract available. Erratum in: Ann Oncol. 2015 Sep;26 Suppl 5:v174-7.

3.

ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation.

Cherny NI; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii143-52. doi: 10.1093/annonc/mdu238. No abstract available.

4.

ESMO Clinical Practice Guidelines on palliative care: advanced care planning.

Schrijvers D, Cherny NI; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii138-42. doi: 10.1093/annonc/mdu241. No abstract available.

5.

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Van Cutsem E, Cervantes A, Nordlinger B, Arnold D; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9. doi: 10.1093/annonc/mdu260. Epub 2014 Sep 4. No abstract available. Erratum in: Ann Oncol. 2015 Sep;26 Suppl 5:v174-7.

6.

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Eichenauer DA, Engert A, André M, Federico M, Illidge T, Hutchings M, Ladetto M; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii70-5. doi: 10.1093/annonc/mdu181. Epub 2014 Jul 25. No abstract available.

7.

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Fenaux P, Haase D, Sanz GF, Santini V, Buske C; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii57-69. doi: 10.1093/annonc/mdu180. Epub 2014 Jul 25. No abstract available.

8.

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Dreyling M, Ghielmini M, Marcus R, Salles G, Vitolo U, Ladetto M; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii76-82. doi: 10.1093/annonc/mdu200. Epub 2014 Aug 13. No abstract available.

9.

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Reck M, Popat S, Reinmuth N, De Ruysscher D, Kerr KM, Peters S; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii27-39. doi: 10.1093/annonc/mdu199. Epub 2014 Aug 11. No abstract available.

10.

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.

Bellmunt J, Orsola A, Leow JJ, Wiegel T, De Santis M, Horwich A; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii40-8. doi: 10.1093/annonc/mdu223. Epub 2014 Aug 5. No abstract available.

11.

High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii93-101. doi: 10.1093/annonc/mdu050. Epub 2014 Apr 29. No abstract available.

12.

Bone health in cancer patients: ESMO Clinical Practice Guidelines.

Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii124-37. doi: 10.1093/annonc/mdu103. Epub 2014 Apr 29.

13.

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Glimelius B, Tiret E, Cervantes A, Arnold D; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi81-8. doi: 10.1093/annonc/mdt240. No abstract available.

14.

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandalà M, Cervantes A, Arnold D; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72. doi: 10.1093/annonc/mdt354. No abstract available.

15.

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Stahl M, Mariette C, Haustermans K, Cervantes A, Arnold D; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi51-6. doi: 10.1093/annonc/mdt342. No abstract available.

16.

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi33-8. doi: 10.1093/annonc/mdt353. No abstract available.

17.

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi24-32. doi: 10.1093/annonc/mdt333. No abstract available.

18.

Waldenstrom's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Buske C, Leblond V, Dimopoulos M, Kimby E, Jäger U, Dreyling M; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi155-9. doi: 10.1093/annonc/mdt298. No abstract available.

19.

Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Zucca E, Copie-Bergman C, Ricardi U, Thieblemont C, Raderer M, Ladetto M; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi144-8. doi: 10.1093/annonc/mdt343. No abstract available.

20.

Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Oldenburg J, Fosså SD, Nuver J, Heidenreich A, Schmoll HJ, Bokemeyer C, Horwich A, Beyer J, Kataja V; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi125-32. doi: 10.1093/annonc/mdt304. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk